| | | | | |
ANIK Anika Therapeutics Inc | €18,3163 | +0,61% | €252,46M | €76,49K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | €8,9783 | +0,05% | €252,38M | €6,08K | |
GPAC General Purpose Acquisition Corp. Class A Ordinary Shares | €8,6658 | +0,80% | €252,34M | €12,23K | |
BPRN Princeton Bancorp, Inc. Common Stock (PA) | €36,4013 | +1,02% | €252,21M | €16,36K | |
| €37,1035 | -0,60% | €252,06M | €8,24K | |
ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares | €8,5544 | -0,10% | €252,05M | €157,55 | |
HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares | €8,6315 | +0,00% | €252,04M | €700,45 | |
SLN Silence Therapeutics Plc American Depository Share | €11,2903 | -3,12% | €251,98M | €501,09K | |
MTNE CH4 Natural Solutions Corporation | €8,4731 | +0,05% | €251,65M | €2,91K | |
RXST RxSight, Inc. Common Stock | €5,2191 | -1,06% | €251,45M | €567,73K | |
NHIC NewHold Investment Corp III Class A Ordinary shares | €9,0939 | -0,14% | €251,34M | €500,01K | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | €8,5844 | +0,00% | €251,31M | €547,17 | |
CNXU Conexeu Sciences Inc. Common Stock | €8,0278 | +4,63% | €251,12M | €210,59K | |
| €9,0682 | +2,52% | €250,88M | €1,24M | |
JCE Nuveen Core Equity Alpha Fund | €14,5314 | +0,03% | €250,71M | €13,91K | |
